Indeed, gene expression data from the TCGA database pointed to a negative correlation of ROR2 expression with an active canonical WNT signature in breast cancer patients [91], suggesting that the inhibitory effect of ROR2 also occurs in vivo. Here, ROR2 is linked to breast cancer.